Literature DB >> 15051516

Modification of peptide interaction with MHC creates TCR partial agonists.

Kelli R Ryan1, Lisa K McNeil, Chinh Dao, Peter E Jensen, Brian D Evavold.   

Abstract

We report the creation of TCR partial agonists by the novel approach of manipulating the interaction between immunogenic peptide and MHC. Amino acids at MHC anchor positions of the I-E(k)-restricted hemoglobin (64-76) and moth cytochrome c (88-103) peptides were exchanged with MHC anchor residues from the low affinity class II invariant chain peptide (CLIP), resulting in antigenic peptides with altered affinity for MHC class II. Several low affinity peptides were identified as TCR partial agonists, as defined by the ability to stimulate cytolytic function but not proliferation. For example, a peptide containing methionine substitutions at positions one and nine of the I-E(k) binding motif acted as a partial agonist for two hemoglobin-reactive T cell clones (PL.17 and 3.L2). The identical MHC anchor substitutions in moth cytochrome c (88-103) also created a partial agonist for a mCC-reactive T cell (A.E7). Thus, peptides containing MHC anchor modifications mediated similar T cell responses regardless of TCR fine specificity or antigen reactivity. This data contrasts with the unique specificity among individual clones demonstrated using traditional altered peptide ligands containing substitutions at TCR contact residues. In conclusion, we demonstrate that altering the MHC anchor residues of the immunogenic peptide can be a powerful method to create TCR partial agonists.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051516     DOI: 10.1016/j.cellimm.2004.01.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

Review 1.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

Review 2.  CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.

Authors:  Andrea J Sant; Anthony T DiPiazza; Jennifer L Nayak; Ajitanuj Rattan; Katherine A Richards
Journal:  Immunol Rev       Date:  2018-07       Impact factor: 12.988

Review 3.  Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.

Authors:  Scheherazade Sadegh-Nasseri; Sarat K Dalai; Laura C Korb Ferris; Saied Mirshahidi
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

4.  Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR.

Authors:  Brian A Cobb; Dennis L Kasper
Journal:  Glycobiology       Date:  2008-06-04       Impact factor: 4.313

5.  A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis.

Authors:  Nicole N M Trager; Jonathan T Butler; Jennifer Harmon; Joshua Mount; Maria Podbielska; Azizul Haque; Naren L Banik; Craig C Beeson
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

6.  Thymoproteasome subunit-β5T generates peptide-MHC complexes specialized for positive selection.

Authors:  Yan Xing; Stephen C Jameson; Kristin A Hogquist
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

Review 7.  Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see).

Authors:  Ludger Klein; Bruno Kyewski; Paul M Allen; Kristin A Hogquist
Journal:  Nat Rev Immunol       Date:  2014-05-16       Impact factor: 53.106

8.  Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands.

Authors:  Liliana G Petrich de Marquesini; Antonis K Moustakas; Ian J Thomas; Li Wen; George K Papadopoulos; F Susan Wong
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

Review 9.  How Does B Cell Antigen Presentation Affect Memory CD4 T Cell Differentiation and Longevity?

Authors:  Robin A Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

10.  Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology.

Authors:  J Lori Blanchfield; Shayla K Shorter; Brian D Evavold
Journal:  Front Immunol       Date:  2013-07-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.